Orleans Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Orleans Capital Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	23,055 -3,845	-14%	-$195K	0.59%	52
2026 Q1	$1.44M	Sell	26,900 -2,260	-8%	-$133K	0.97%	41
2025 Q4	$1.81M	Sell	29,160 -5,120	-15%	-$316K	1.13%	27
2025 Q3	$2.06M	Sell	34,280 -12,015	-26%	-$735K	1.33%	26
2025 Q2	$2.9M	Sell	46,295 -1,105	-2%	-$66.4K	1.54%	22
2025 Q1	$2.85M	Sell	47,400 -355	-0.7%	-$22.1K	1.68%	24
2024 Q4	$3.06M	Sell	47,755 -470	-1%	-$27.9K	1.71%	23
2024 Q3	$2.86M	Buy	48,225 +300	+0.6%	+$17.1K	1.62%	23
2024 Q2	$2.69M	Sell	47,925 -430	-0.9%	-$24.1K	1.71%	23
2024 Q1	$2.83M	Buy	48,355 +695	+1%	+$39.3K	1.86%	21
2023 Q4	$2.57M	Buy	47,660 +140	+0.3%	+$6.84K	1.73%	21
2023 Q3	$2.3M	Sell	47,520 -430	-0.9%	-$22.9K	1.71%	21
2023 Q2	$2.71M	Sell	47,950 -1,230	-3%	-$67.7K	1.92%	20
2023 Q1	$2.65M	Buy	49,180 +1,710	+4%	+$91K	1.96%	21
2022 Q4	$2.5M	Sell	47,470 -2,000	-4%	-$101K	1.91%	21
2022 Q3	$2.33M	Sell	49,470 -3,500	-7%	-$182K	1.95%	20
2022 Q2	$2.67M	Sell	52,970 -255	-0.5%	-$13.9K	2%	21
2022 Q1	$3.25M	Sell	53,225 -1,125	-2%	-$67.1K	2.02%	18
2021 Q4	$3.58M	Sell	54,350 -20	-0%	-$1.28K	2.03%	20
2021 Q3	$3.41M	Buy	54,370 +40	+0.1%	+$2.55K	2.18%	17
2021 Q2	$3.27M	Sell	54,330 -1,140	-2%	-$65.9K	2.09%	16
2021 Q1	$3.05M	Buy	55,470 +2,310	+4%	+$128K	2.08%	17
2020 Q4	$2.9M	Buy	53,160 +2,790	+6%	+$146K	2.09%	21
2020 Q3	$2.52M	Buy	50,370 +2,940	+6%	+$142K	1.92%	19
2020 Q2	$2.09M	Buy	+47,430	New	+$2.03M	1.71%	22
2020 Q1	–	Sell	-38,340	Closed	-$1.69M	–	56
2019 Q4	$1.69M	Buy	38,340 +840	+2%	+$35.3K	1.18%	37
2019 Q3	$1.54M	Buy	+37,500	New	+$1.54M	1.14%	41

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Orleans Capital Management's IHI Position: Q2 2026 in Review

Orleans Capital Management reduced its iShares US Medical Devices ETF (IHI) stake by 14% in Q2 2026, selling an estimated $195K and leaving 23,055 shares worth $1.14M. The position accounts for 0.59% of the portfolio, ranked #52.

Orleans Capital Management first reported a position in IHI in Q3 2019 and has held it in 27 quarters since. The position peaked at $3.58M in Q4 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Orleans Capital Management held 23,055 shares of iShares US Medical Devices ETF worth $1.14M as of Q2 2026.
Orleans Capital Management sold 3,845 iShares US Medical Devices ETF shares in Q2 2026, an estimated $195K.
iShares US Medical Devices ETF made up 0.59% of Orleans Capital Management's portfolio in Q2 2026, its #52 holding.
Orleans Capital Management first reported a position in iShares US Medical Devices ETF in Q3 2019 and has held it in 27 quarters since.
Orleans Capital Management's iShares US Medical Devices ETF position peaked at $3.58M in Q4 2021.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Orleans Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.